PURPOSE: To report on outcomes after proton beam radiotherapy of @entity320 . METHODS AND MATERIALS: Between 1993 and 2004, 88 @entity1 with @entity320 received proton beam radiotherapy, with 53.1 Gy in 4 fractions. RESULTS: The @entity1 had a mean age of 52 years and a median follow-up of 2.7 years. The @entity5 had a median diameter of 4.3 mm, involving more than 2 clock hours of @entity1539 in 32% of @entity1 and more than 2 hours of angle in 27%. The ciliary body was involved in 20%. @entity231 was present in 13 @entity1 before treatment and subsequently developed in another 18. @entity231 had a 4-year rate of 63% and by @entity797 analysis was related to age (p = 0.05), initial @entity227 (p < 0.0001), @entity1539 involvement (p < 0.0001), and @entity5 thickness (p < 0.0001). @entity726 was present before treatment in 13 @entity1 and developed after treatment in another 3. Three eyes were enucleated, all because of recurrence, which had an actuarial 4-year rate of 3.3% (95% CI 0-8.0%). CONCLUSIONS: Proton beam radiotherapy of @entity320 is well tolerated, the main problems being radiation- @entity231 , which was treatable, and preexisting @entity726 , which in several @entity1 was difficult to control.

Proton beam radiotherapy of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity227 :: ('MESH:D014786', 'Disease') :: ['visual loss'] @entity1539 :: ('MESH:D007499', 'Disease') :: ['iris'] @entity231 :: ('MESH:D002386', 'Disease') :: ['Cataract', 'cataract'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'tumors'] @entity797 :: ('1351', 'Gene') :: ['Cox'] @entity726 :: ('MESH:D005901', 'Disease') :: ['Glaucoma', 'glaucoma'] @entity320 :: ('MESH:D008545', 'Disease') :: ['iris melanoma']
@entity320 :: (MESH:D008545,Disease) :: ['iris melanoma']
